← Back to Search

Ohio RETAIN Program for Employment Retention Among Disabled Individuals

N/A

Recruiting

Led By Jill Berk, PhD

Research Sponsored by Mathematica Policy Research, Inc.

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Qualifying Cardiovascular procedure: (a) CABG (Coronary Artery Bypass Graft) scheduled or done; (b) TAVR (Coronary Valve replacement with open heart entry to exclude trans-catheter) approach scheduled or done; (c) (Abdominal Aortic Aneurysm) open entry approach scheduled or done; (d) Aorto-bifemoral bypass with activity restrictions for 4 weeks or more scheduled or done; (e) Cardiac Catheterization with stent placement with: i) Cardiac Rehab ordered at time of Cardiac Catheterization or ii) No Cardiac Rehab ordered at time of Cardiac Catheterization, but Cardiac Rehab has been ordered at Cardiac Catheterization follow up appointment.

Has a qualifying musculoskeletal injury or exacerbation or a qualifying cardiovascular procedure

Timeline

Screening 3 weeks

Treatment Varies

Follow Up measured in the 12 months after enrollment

Awards & highlights

Study Summary

This trial is testing a program to help people who are injured or ill stay employed instead of relying on disability programs.

Who is the study for?

The Ohio RETAIN trial is for people aged 18-65 living in specific counties of Ohio who have had a recent musculoskeletal injury or cardiovascular procedure, are currently working or job-seeking, and have work limitations prescribed by a doctor. It's not for those retired, with workers' comp claims, on disability insurance, substance abuse issues, legal representation, pregnancy, terminal disease or multi-system trauma.Check my eligibility

What is being tested?

Ohio RETAIN aims to help individuals stay employed after an injury or illness that could lead them to leave the workforce. The program includes medical services and coordination to facilitate staying at work or returning as soon as possible. This evaluation will measure how well it works and if it's cost-effective.See study design

What are the potential side effects?

Since this intervention involves employment support services rather than medical treatment, traditional side effects associated with medications are not applicable here.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below

Select...

I have a recent significant injury or had a heart-related procedure.

Select...

I am between 18 and 65 years old.

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ measured over the three months in the fourth quarter after enrollment

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~measured over the three months in the fourth quarter after enrollment

This trial's timeline: 3 weeks for screening, Varies for treatment, and measured over the three months in the fourth quarter after enrollment for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Enrollee earnings in the fourth quarter after enrollment

Share of enrollees employed in the fourth quarter after enrollment

Share of enrollees that applied for SSDI or SSI during the 12 months after enrollment

Trial Design

2Treatment groups

Experimental Treatment

Active Control

Group I: RETAIN ProgrammingExperimental Treatment1 Intervention

The experimental group receives the full set of RETAIN intervention activities.

Group II: ControlActive Control1 Intervention

Medical providers who treat both treatment and control group enrollees receive training on stay-at-work/return-to-work best practices

0 / 3Eligibility criteria met

Find a Location

Who is running the clinical trial?

Mathematica Policy Research, Inc.Lead Sponsor

57 Previous Clinical Trials

6,115,293 Total Patients Enrolled

3 Trials studying Disability

9,240 Patients Enrolled for Disability

Social Security AdministrationUNKNOWN

2 Previous Clinical Trials

5,240 Total Patients Enrolled

1 Trials studying Disability

2,040 Patients Enrolled for Disability

Jill Berk, PhDPrincipal InvestigatorMathematica Policy Research, Inc.

4 Previous Clinical Trials

12,440 Total Patients Enrolled

3 Trials studying Disability

9,240 Patients Enrolled for Disability

Media Library

Ohio RETAIN Clinical Trial Eligibility Overview. Trial Name: NCT05219045 — N/A

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Does this research experiment admit participants aged below 85 years?

"This trial has a maximum age limit of 65 and the lower threshold for enrollment is 18, in accordance with its stated eligibility criteria."

Answered by AI

Are participants still being accepted into this clinical research initiative?

"Affirmative. According to records on clinicaltrials.gov, this medical trial is still seeking participants as of today's date. It was initially launched on January 19th 2022 and has since been modified once, with the last update occurring on January 20th 2022. 3200 patients are being recruited from one site for this study."

Answered by AI

Who is eligible for this research program?

"This clinical trial is currently enrolling 3200 individuals aged 18 to 65 who have a disability. To be eligible, patients must satisfy the following conditions: inhabit Youngstown (Mahoning, Columbiana and Trumbull Counties), Toledo (Lucas County) or Cincinnati (Butler, Clermont Hamilton and Warren Counties); submit FMLA paperwork with work limitations specified in office notes; suffer from an illness/injury causing them to cease working for a prolonged period; possess musculoskeletal injury that has arisen within the last three months; undertake CABG (Coronary Artery Bypass Graft)/ T"

Answered by AI

What is the enrollment quota for this clinical trial?

"Affirmative. Clinicaltrials.gov specifies that this medical study, first posted on January 19th 2022, is actively recruiting potential participants. A total of 3200 people are needed at a single clinical trial site."

Answered by AI

Recent research and studies

clinicaltrials.govStudy

Ohio RETAIN Impact Evaluation

2022. "Ohio RETAIN Impact Evaluation". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT05219045.